NCT05087303

Telemedicine for Children With Sickle Cell Disease

Telemedicine for Pediatric Sickle Cell Patients in Medically Underserved Areas

• Status: Active Not Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Indiana University · Academic / Other
• Sex: All
• Age: 16 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to learn more about how the use of two different types of telemedicine (distance medical care) can address barriers to receiving comprehensive sickle cell care, and whether care can be improved. Aim 1: Adapt two telemedicine models (i.e., hub-and-spoke; direct-to-consumer) for use with children with SCD using caregiver input from our preliminary K12 work. Aim 2: Demonstrate the feasibility of the telemedicine models developed in Aim 1 as the models undergo successive stakeholder refinement during use in actual clinical care. Aim 3: Evaluate the effectiveness of the refined models from Aim 2 in a pre/post study by assessing (a) process of care measures, (b) provider satisfaction, (c) caregiver/patient-centered outcomes, and (d) clinical outcomes and healthcare utilization.

Conditions

• Anemia, Sickle Cell

Interventions

Type	Name	Description
OTHER	Types of Telemedicine Delivery Models	Each arm delivers standard sickle cell care using a different model based on patient location.

Timeline

• Start date: 2022-11-23
• Primary completion: 2026-03-30
• Completion: 2026-04-30
• First posted: 2021-10-21
• Last updated: 2026-03-12

Locations

1 site across 1 country: United States